Israel Englander Adc Therapeutics Sa Transaction History

Millennium Management LLC

$192 Billion
Q4 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Adc Therapeutics Sa stock. As of the latest transaction made, Millennium Management LLC holds 411,124 shares of ADCT stock, worth $735,911. This represents 0.0% of its overall portfolio holdings.

Number of Shares

411,124

Previous 712,401 42.29%

Holding current value

$735,911

Previous $2.24 Million 63.55%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$1.89 - $3.48 $569,413 - $1.05 Million	-301,277 Reduced 42.29%	411,124 $818,000
Q3 2024 Nov 14, 2024	SELL	$2.59 - $4.01 $269,502 - $417,260	-104,055 Reduced 12.74%	712,401 $2.24 Million
Q2 2024 Aug 14, 2024	SELL	$2.55 - $5.09 $494,651 - $987,363	-193,981 Reduced 19.2%	816,456 $2.58 Million
Q1 2024 May 15, 2024	SELL	$1.66 - $5.29 $2.76 Million - $8.79 Million	-1,662,373 Reduced 62.2%	1,010,437 $4.54 Million
Q4 2023 Feb 14, 2024	BUY	$0.47 - $1.79 $586,870 - $2.24 Million	1,248,661 Added 87.68%	2,672,810 $4.44 Million
Q2 2023 Aug 14, 2023	SELL	$1.9 - $2.66 $701,181 - $981,654	-369,043 Reduced 20.58%	1,424,149 $3.06 Million
Q1 2023 May 15, 2023	SELL	$1.92 - $5.45 $3.09 Million - $8.76 Million	-1,607,928 Reduced 47.28%	1,793,192 $3.5 Million
Q4 2022 Feb 14, 2023	BUY	$2.87 - $5.24 $8.56 Million - $15.6 Million	2,980,867 Added 709.3%	3,401,120 $13.1 Million
Q3 2022 Nov 14, 2022	BUY	$4.66 - $10.31 $1.69 Million - $3.74 Million	362,288 Added 625.01%	420,253 $2.03 Million
Q2 2022 Aug 15, 2022	BUY	$5.96 - $14.99 $345,471 - $868,895	57,965 New	57,965 $461,000
Q1 2022 May 16, 2022	SELL	$13.28 - $20.03 $536,073 - $808,551	-40,367 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$19.29 - $31.51 $778,679 - $1.27 Million	40,367 New	40,367 $815,000
Q1 2021 May 17, 2021	SELL	$22.75 - $34.05 $675,197 - $1.01 Million	-29,679 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$25.26 - $38.02 $52,237 - $78,625	-2,068 Reduced 6.51%	29,679 $950,000
Q3 2020 Nov 16, 2020	BUY	$32.87 - $51.05 $554,188 - $860,703	16,860 Added 113.25%	31,747 $1.05 Million
Q2 2020 Aug 14, 2020	BUY	$29.65 - $46.81 $441,399 - $696,860	14,887 New	14,887 $697,000

Others Institutions Holding ADCT

# of Institutions

Shares Held

55.3M

Call Options Held

24.1K

Put Options Held

44.7K

View Full List

About ADC Therapeutics SA

Ticker ADCT
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,645,296
Market Cap $139M
Description
ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...

More about ADCT

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account